BURLINGAME, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)DIABETES TECHNOLOGY SOCIETY, founded in 2001, is a community nonprofit in the Diseases & Disorders sector that reported $1.0M in total revenue in fiscal year 2025. Revenue fell 47% from the prior year — a significant decline worth monitoring. Expenses of $1.6M exceeded revenue, resulting in a 57% operating deficit.
TO FACILITATE RESEARCH INTO THE TREATMENT, MONITORING, DIAGNOSIS AND PREVENTION OF DIABETES.
TO FURTHER EDUCATION PROFESSIONALS AND THE PUBLIC ON THE TREATMENT, MONITORING, DIAGNOSIS AND PREVENTION OF DIABETES. THIS WAS ACHIEVED BY HOLDING EDUCATIONAL CONFERENCES, MAINTAINING AN...
TO FURTHER EDUCATION PROFESSIONALS AND THE PUBLIC ON THE TREATMENT, MONITORING, DIAGNOSIS AND PREVENTION OF DIABETES. THIS WAS ACHIEVED BY HOLDING EDUCATIONAL CONFERENCES, MAINTAINING AN INFORMATIONAL WEBSITE, HOLDING AN ONGOING PODCAST WITH LEADERS IN THE DIABETES TECHNOLOGY FIELD, MAINTAINING A SPANISH/ENGLISH DUAL-LANGUAGE INFORMATIONAL WEBSITE AND PUBLISHING 204 TECHNICAL ARTICLES AND 13 RESEARCH ARTICLES ABOUT DIABETES AND DIABETES TECHNOLOGY. CONFERENCES HELD IN 2025, THE NUMBER OF ATTENDEES AND OTHER PROJECTS ARE AS FOLLOWS:1.TOOLS TO DISTINGUISH T1D & T2D IN ADULTS (TOOLS PROJECT)MEETING #1: 2/4/2025, 14 ATTENDEESMEETING #2: 2/5/2025, 14 ATTENDEESMEETING #3: 5/29/2025: 29 ATTENDEESMEETING #4: 8/13/2025, 14 ATTENDEES2. INTEGRATION OF CONNECTED DIABETES DEVICE DATA INTO THE ELECTRONIC HEALTH RECORD #2 (ICODE-2)SEPTEMBER 18, 2025NO. OF ATTENDEES: 403. THE ROLE OF THE GLYCEMIA RISK INDEX DIABETES TECHNOLOGY MEETING (GRI MEETING)OCTOBER 27, 2025NO. OF ATTENDEES: 484. DIABETES TECHNOLOGY MEETING (IN-PERSON) (DTM 2025)OCTOBER 28-30, 2025NO. OF ATTENDEES: 5005. THE USE OF CGM TO DIAGNOSE STAGE 2 T1D CONSENSUS PANEL (IN-PERSON PRESENTATION AT THE 2025 DTM)OCTOBER 30, 2025 NO. OF ATTENDEES: 500ONGOING PROJECTS:1. DIABETES RESEARCH HUB (DRH) - ONGOING PROJECTTHE DRH IS A COMPREHENSIVE DATA ECOSYSTEM DESIGNED TO ACCELERATE BREAKTHROUGHS IN DIABETES RESEARCH. WE EMPOWER RESEARCHERS BY UNLOCKING THE POTENTIAL OF DATA TRAPPED IN PROPRIETARY MEDICAL DEVICES AND HEALTH SYSTEMS. BY CREATING A SECURE AND USER-FRIENDLY PLATFORM FOR DATA COLLECTION, ANALYSIS, AND COLLABORATION, THE DRH FUELS NEXT-GENERATION RESEARCH USING AI AND ML TO DEVELOP PERSONALIZED AND EFFECTIVE SOLUTIONS FOR DIABETES.2. THE DCB OPEN INNOVATION CHALLENGEIN COLLABORATION WITH DIABETES CENTER BERNEONGOING - LAUNCHED ON 4/1/2024 & FEATURED AT THE DTM 2025 ON 10/30/20253. DIABETES TECHNOLOGY REPORT(DTS PODCAST)DTS LAUNCHED AN ONGOING PODCAST WITH LEADERS IN THE DIABETES TECHNOLOGY FIELD.4. SALUDDIABETES.ORGDTS LAUNCHED A SPANISH/ENGLISH DUAL-LANGUAGE WEBSITE THAT SUMMARIZES RECENT PUBLICATIONS IN DIABETES AND HEALTH FOR THE LAYPERSON.5. OPTIMIZING LIFESTYLE INTERVENTIONS FOR REVERSING INSULIN RESISTANCE - ONGOING PROJECTTO ANALYZE MEDICAL LITERATURE FOR INTERVENTIONS THAT IMPROVE INSULIN SENSITIVITY (EITHER BY AN EFFECT ON THE LIVER, MUSCLES, OR PRODUCTION OF INSULIN OR NATURAL GLP-1RA HORMONE) THAT COULD BECOME PART OF A BEHAVIORAL TOOL TO BE USED FOR PEOPLE WITH PREDIABETES OR WHO ARE AT RISK OF DIABETES TO DECREASE THEIR RISK OF DEVELOPING TYPE 2 DIABETES.6. JDST (JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY)PUBLISHED 204 TECHNICAL ARTICLES ABOUT DIABETES AND DIABETES TECHNOLOGY AFTER RECEIVING 628 ARTICLES TO REVIEW.7. PUBLICATION OF 13 RESEARCH ARTICLES BY DTS STAFF LISTED BELOW:-EVALUATING THE CLINICAL UTILITY OF THE GLYCEMIA RISK INDEX.J DIABETES SCI TECHNOL. 2025 OCT 14:19322968251382604. DOI: 10.1177/19322968251382604. ONLINE AHEAD OF PRINT. PMID: 41216978 FREE PMC ARTICLE.-MACHINE LEARNING TO DIAGNOSE COMPLICATIONS OF DIABETES. J DIABETES SCI TECHNOL. 2025 NOV;19(6):1650-1670. DOI: 10.1177/19322968251365245. EPUB 2025 SEP 11. PMID: 40932163 FREE PMC ARTICLE. REVIEW.-CONTINUOUS GLUCOSE MONITORING DATA ANALYSIS 2.0: FUNCTIONAL DATA PATTERN RECOGNITION AND ARTIFICIAL INTELLIGENCE APPLICATIONS. J DIABETES SCI TECHNOL. 2025 NOV;19(6):1515-1527. DOI: 10.1177/19322968251353228. EPUB 2025 AUG 14. PMID: 40814224 FREE PMC ARTICLE.-GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS AND PERI-PROCEDURAL ASPIRATION RISK. J ENDOCR SOC. 2025 JUL 10;9(9):BVAF088. DOI: 10.1210/JENDSO/BVAF088. ECOLLECTION 2025 SEP. PMID: 40893948 FREE PMC ARTICLE. REVIEW.-THE NEED TO TRANSITION FROM PAPER TO ELECTRONIC INSTRUCTIONS FOR USE FOR DIABETES DEVICES. NPJ DIGIT MED. 2025 JUN 13;8(1):356. DOI: 10.1038/S41746-025-01720-0. PMID: 40514391 FREE PMC ARTICLE.-DIABETES DEVICES: A GROWING ENVIRONMENTAL BURDEN. DIABETES RES CLIN PRACT. 2025 AUG;226:112307. DOI: 10.1016/J.DIABRES.2025.112307. EPUB 2025 JUN 3. PMID: 40473032 NO ABSTRACT AVAILABLE.-USE OF CONTINUOUS GLUCOSE MONITORING TO DIAGNOSE STAGE 2 TYPE 1 DIABETES. J DIABETES SCI TECHNOL. 2025 JUL;19(4):1109-1127. DOI: 10.1177/19322968251333441. EPUB 2025 MAY 30. PMID: 40444471 FREE PMC ARTICLE. REVIEW.-ENVISIONING TOOLS TO HELP CLASSIFY TYPE 1 DIABETES AND TYPE 2 DIABETES IN NEW-ONSET ADULT DIABETES. J DIABETES SCI TECHNOL. 2025 JUL;19(4):1137-1143. DOI: 10.1177/19322968251329055. EPUB 2025 MAR 28. PMID: 40152433 FREE PMC ARTICLE.-QUANTIFYING ENVIRONMENTAL WASTE FROM DIABETES DEVICES IN THE U.S. DIABETES CARE. 2025 JUL 1;48(7):1198-1203. DOI: 10.2337/DC24-2522. PMID: 40072890.-HOW TO PROVIDE ADDITIONAL OVERSIGHT TO ENSURE THAT REMOTE PATIENT MONITORING FOR PEOPLE WITH DIABETES IS BEING USED AND BILLED APPROPRIATELY. DIABETES SCI TECHNOL. 2025 MAY;19(3):843-849. DOI: 10.1177/19322968241309357. EPUB 2025 JAN 16. PMID: 39819165 FREE PMC ARTICLE.-HOW THE DIABETES RESEARCH HUB WILL MODERNIZE AND ENHANCE DIABETES DATA UTILIZATION. J DIABETES SCI TECHNOL. 2026 JAN;20(1):3-6. DOI: 10.1177/19322968241306129. EPUB 2024 DEC 21. PMID: 39707843 FREE PMC ARTICLE.-COMPARISON OF THE GLYCEMIA RISK INDEX AND TIME IN RANGE IN A CASE SERIES OF USING AUTOMATED INSULIN DELIVERY TO IMPROVE GLYCEMIC CONTROL IN PEOPLE WITH TYPE 1 DIABETES AND END STAGE KIDNEY DISEASE ON HEMODIALYSIS. DIABETES RES CLIN PRACT. 2025 JAN;219:111940. DOI: 10.1016/J.DIABRES.2024.111940. EPUB 2024 NOV 29. PMID: 39615793 NO ABSTRACT AVAILABLE.-CONSENSUS REPORT ON THE USE OF CONTINUOUS GLUCOSE MONITORING IN CHRONIC KIDNEY DISEASE AND DIABETES. J DIABETES SCI TECHNOL. 2025 JAN;19(1):217-245. DOI: 10.1177/19322968241292041. EPUB 2024 NOV 29. PMID: 39611379 FREE PMC ARTICLE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $1,029,388 | $1,925,694 | -0.5% |
| Expenses | $1,615,150 | $1,539,248 | +0.0% |
| Net Income | $-585,762 | $386,446 | -2.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| DR DAVID KLONOFF MD | PRESIDENT | 40.00 |
Officer
Director
|
$297,813 | $8,934 | $306,747 |
| HENRY WYKOWSKI | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| AVERY DIAMOND | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DR GERALD R SYDORAK MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $1,029,388 | $1,615,150 | $1,420,913 | $-585,762 |
| 2024 | $1,925,694 | $1,539,248 | $2,007,874 | $386,446 |
| 2023 | $1,379,124 | $1,103,400 | $1,611,702 | $275,724 |
| 2022 | $1,163,946 | $1,267,548 | $1,334,588 | $-103,602 |
| 2021 | $1,063,604 | $891,137 | $1,434,867 | $172,467 |
| 2020 | $922,975 | $806,021 | $1,261,104 | $116,954 |
| 2019 | $1,183,282 | $1,323,809 | $1,172,416 | $-140,527 |
| 2018 | $1,552,220 | $1,267,395 | $1,328,236 | $284,825 |
Compare DIABETES TECHNOLOGY SOCIETY with other nonprofits in California and across the country.